Apex Perspectives
-
Wegovy Was Not First to Market: Evolution of GLP-1s
Wegovy arrived on the weight management scene with a clear advantage: it wasn’t the first GLP/GLP-GIP agent, but it raised the bar for efficacy and dosing convenience. This introduction to the market demonstrated that timing and product improvement are critical to success. Our discussion will trace the evolution from Byetta’s and Saxenda’s earlier dosing schedules…
-
Expanding the TPP: Advanced Considerations for Market Access Success
In our previous exploration of the Target Product Profile (TPP), we laid the groundwork for understanding its pivotal role in navigating the complex terrain of market access. But the TPP is not just a static document: it’s a living blueprint that must adapt to the evolving business landscape. In this follow-up post, we expand on…
-
The TPP Guide: Unlocking Market Access in Biopharma
In the fast-paced business of biopharma, the journey from product discovery to market access is fraught with complexity. A Target Product Profile (TPP) serves not just as a blueprint for development but as a strategic compass across functions, including market access and pricing. As seasoned professionals know, a TPP’s value extends beyond clinical development into…
-
5 Ways AI Will Revolutionize Pharma Market Access
The biopharmaceutical landscape is on the cusp of a transformative shift as artificial intelligence (AI), particularly Large Language Models (LLMs) and machine learning, take center stage in redefining market access strategies. In an industry where understanding and integrating complex data sets becomes pivotal, AI emerges as a potent ally. But what distinguishes AI from static…
-
Understanding Drug Pricing Strategies with GLP-1 Agents
In the dynamic world of biopharma, understanding drug pricing strategies is more than just an academic exercise—it’s a crucial element of market success. Glucagon-like peptide 1 (GLP-1) agonists1 such as Novo Nordisk’s Ozempic, Novo Nordisk’s Wegovy, Eli Lilly’s Mounjaro, and Eli Lilly’s Zepbound offer a set of case studies that are helpful in illustrating common…
-
Understanding Drug Pricing: A Primer for Biopharma Professionals
Imagine venturing into a realm where scientific innovation collides with economic principles, where the quest to alleviate suffering balances with financial realities. Welcome to the world of drug pricing. In the biopharma sector, understanding the nuances of drug pricing isn’t just a necessity—it’s an art form. As we delve into this realm, we unravel the…
-
The Pillars of an Effective Market Access Strategy
Market access strategy is the integrated set of choices that ensure a drug, biologic, or medical device is available and can be efficiently and sustainably utilized by those who need it. Effective execution requires a symphony of activities across diverse functions within a biopharma organization and often extends into collaboration with external stakeholders. Here we…
-
5 Trends Shaping Biopharma Market Access in 2023
The biopharmaceutical landscape is in a state of continual evolution, driven by scientific advancements, regulatory shifts, and market dynamics. As we venture deeper into 2023, several notable trends are shaping the market access paradigm, warranting attention from stakeholders across the industry spectrum. From policy enactments like the Inflation Reduction Act to the burgeoning realm of…